Marksans Pharma's Goa Facility Gets Australian TGA Approval for Exports

Marksans Pharma has stated that its pharmaceutical manufacturing unit situated at Plot A-1, Phase 1-A, Verna Industrial Estate, Goa, India, has been granted the approval from the...

Government to Launch Key TB Drug Rifampicin this Year

By the end of this year, India will commence domestic manufacture of Rifampicin, a first-line anti-tubercular medicine. According to official sources, “Rifampicin is at an advanced stage of execution and is expected to get commissioned later this yea

Sun Pharma and Zydus Recall Products in the US, Says USFDA Report

The US FDA said that Sun and Zydus Pharmaceuticals are recalling products from the American market due to manufacturing errors. Sun Pharma Industries, Inc. based in New Jersey is recalling 9,840 bottles of Morphine Sulfate extended-release tablets fo

Poly Medicure Secures EU MDR Validation for Diverse Medical Devices

Poly Medicure is one of the world’s largest manufacturers of medical devices and has recently received Medical Device Regulation (MDR) validation for 54 of its products across diverse specialties such as infusion therapy, surgery & wound care....

Sun Pharma Seeks Approval for $1 Billion Related-Party Transactions in FY26

On Thursday, Sun Pharmaceutical Industries announced that it has requested shareholders' consent for related-party transactions (RPTs) totaling about $1 billion for FY26...

Aurobindo Pharma to Commence Operations of Latest Chinese Facility

Aurobindo Pharma will commence supplies to Europe from its China facility from April onwards, according to Chief Financial Officer Santhanam Subramanian. The Hyderabad-based drug maker commenced operations at the facility in the last week of Novem...

AstraZeneca To Sell Bengaluru Unit as Part of its Monetization Strategy

AstraZeneca Pharma India is set to sell its 64-acre production facility in North Bengaluru as part of a strategic review of its global manufacturing and supply network by its parent company. The deal is expected to generate over ?3,200 crore and a...

Uniphar Expands Global Footprint with Three New Facilities

Uniphar, a global partner for pharmaceutical and medtech manufacturers, is enhancing its international reach by opening three new facilities, strategically located in major global markets such as Raleigh, Lelystad, and Dublin. Uniphar's recent...

AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand

AGC Pharma Chemicals, a leader in pharmaceutical manufacturing with more than 40 years of experience in Contract Development Manufacturing Operations (CDMO) for small molecule APIs located in Barcelona (Spain) and Japan, is enhancing its High...

Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing

Dr. Ashwani Kumar, Ex-Chief Manufacturing & Compliance Officer, Unichem Laboratories Limited, in an exclusive interview with India Pharma Outlook, shares his views on how the pharmaceutical industry manages cost efficiency while maintaining...